3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
24
Burkitt Lymphoma
15
Sarcoma
14
Neoplasms
11
Lymphoma, Follicular
11
Lymphoma
10
Hodgkin Disease
10
Breast Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Triple Negative Breast Neoplasms
8
Ovarian Neoplasms
8
Lymphoma, Non-Hodgkin
8
Endometrial Neoplasms
8
Lymphoma, B-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm Metastasis
5
Fallopian Tube Neoplasms
5
Osteosarcoma
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Wilms Tumor
3
Sarcoma, Ewing
3
Neuroblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, B-Cell, Marginal Zone
3
Leiomyosarcoma
3
Interventions
Cyclophosphamide
3
fludarabine
2
pembrolizumab
1
ibrutinib
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
CA-4948
1
Busulfan
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immune System Diseases
×
Doxorubicin
×
90 days
×
Clear all
No trials found.